Chris Maloof - Aug 15, 2024 Form 4 Insider Report for MeridianLink, Inc. (MLNK)

Role
President, Go To Market
Signature
/s/ Kayla Dailey, as Attorney-in-Fact
Stock symbol
MLNK
Transactions as of
Aug 15, 2024
Transactions value $
-$374,032
Form type
4
Date filed
8/16/2024, 04:39 PM
Previous filing
Jul 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLNK Common Stock, par value $0.001 Options Exercise $462K +27.8K +8.49% $16.61 356K Aug 15, 2024 Direct
transaction MLNK Common Stock, par value $0.001 Options Exercise $1.05M +59.6K +16.76% $17.66 415K Aug 15, 2024 Direct
transaction MLNK Common Stock, par value $0.001 Sale -$1.89M -87.5K -21.05% $21.60 328K Aug 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLNK Stock Option (option to buy) Options Exercise $0 -27.8K -56.25% $0.00 21.6K Aug 15, 2024 Common Stock, par value $0.001 27.8K $16.61 Direct F2
transaction MLNK Stock Option (option to buy) Options Exercise $0 -59.6K -56.25% $0.00 46.4K Aug 15, 2024 Common Stock, par value $0.001 59.6K $17.66 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.40 to $21.95, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 25% of the shares underlying the option vested and became exercisable on May 2, 2023, and the remaining 75% of the shares underlying the option vest and become exercisable in 12 equal quarterly installments thereafter on the first day of the applicable month beginning at the start of the first calendar quarter following May 2, 2023, subject to the reporting person's continued service relationship with the Issuer through each applicable vesting date.
F3 25% of the shares underlying the option vested and became exercisable on June 15, 2023, and the remaining 75% of the shares underlying the option vest and become exercisable in 12 equal quarterly installments thereafter on the first day of the applicable month beginning at the start of the first calendar quarter following June 15, 2023, subject to the Reporting Person's continued service relationship with the Company through each applicable vesting date.